John-Arne Rottingen
Overview
Explore the profile of John-Arne Rottingen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
4972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hembre B, Chokshi M, Hoffman S, Suleman F, Andresen S, Sandberg K, et al.
Global Health
. 2025 Feb;
21(1):3.
PMID: 39893431
Background: What constitutes state`s global power to shape access to medicines? How was it distributed between states and how did this change from 2000 to 2019? In this comparative case...
2.
Davis A, Asma S, Blecher M, Benn C, Ezoe S, Fogstad H, et al.
Lancet
. 2024 Oct;
404(10462):1500-1503.
PMID: 39419053
No abstract available.
3.
Balasegaram M, Outterson K, Rottingen J
Lancet
. 2024 Sep;
404(10461):1385-1387.
PMID: 39312929
No abstract available.
4.
Piddock L, Alimi Y, Anderson J, de Felice D, Moore C, Rottingen J, et al.
Nat Med
. 2024 Sep;
30(9):2432-2443.
PMID: 39227444
The pipeline of new antibiotics is insufficient to keep pace with the growing global burden of drug-resistant infections. Substantial economic challenges discourage private investment in antibiotic research and development (R&D),...
5.
Mendelson M, Lewnard J, Sharland M, Cook A, Pouwels K, Alimi Y, et al.
Lancet
. 2024 May;
403(10443):2551-2564.
PMID: 38797179
Rising antimicrobial resistance (AMR) is a global health crisis for countries of all economic levels, alongside the broader challenge of access to antibiotics. As a result, development goals for child...
6.
Demotes J, Simensen V, Ueda K, Javaid S, Garcia P, Aydin B, et al.
Trials
. 2024 Apr;
25(1):278.
PMID: 38659031
To ensure optimal coordination of the EU-funded COVID-19 platform trials, a double coordination mechanism was established. It included the Trial Coordination Board (TCB) to promote the dialogue between investigators and...
7.
8.
Dzau V, Swaminathan S, Baker C, Bright R, Castillo J, Chuan T, et al.
Lancet
. 2023 Sep;
402(10412):1507-1510.
PMID: 37683681
No abstract available.
9.
Gore C, Morin S, Rottingen J, Kieny M
BMJ Glob Health
. 2023 Sep;
8(9).
PMID: 37669799
Public health voluntary licensing of intellectual property has successfully been applied to increase access to medicines in certain disease areas, producing health benefits and economic savings, particularly in low-income and...
10.
Ardal C, Baraldi E, Busse R, Castro R, Ciabuschi F, Cisneros J, et al.
Lancet
. 2023 Feb;
403(10422):e2-e4.
PMID: 36774936
No abstract available.